- Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.
Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine (2014-01-07)
Tooru Andoh, Takuya Fujimoto, Tamotsu Sudo, Minoru Suzuki, Yoshinori Sakurai, Toshiko Sakuma, Hiroshi Moritake, Tohru Sugimoto, Tamotsu Takeuchi, Hiroshi Sonobe, Alan L Epstein, Yoshinobu Fukumori, Koji Ono, Hideki Ichikawa
PMID24389062
ABSTRACT
Clear cell sarcoma (CCS) is a rare malignant tumor with a poor prognosis. In our previous study, the tumor disappeared under boron neutron capture therapy (BNCT) on subcutaneously-transplanted CCS-bearing animals. In the present study, the tumor disappeared under this therapy on model mice intramuscularly implanted with three different human CCS cells. BNCT led to the suppression of tumor-growth in each of the different model mice, suggesting its potentiality as an alternative to, or integrative option for, the treatment of CCS.
MATERIALS
Product Number
Brand
Product Description
Sigma-Aldrich
D-(−)-Fructose, ≥99% (HPLC), BioReagent, suitable for cell culture, suitable for insect cell culture
Supelco
D-(−)-Fructose, analytical standard, analytical standard for fructose assay kit, for use with enzymatic assay kit FA20
Boron, monofilament, 20m, diameter 0.2mm
Sigma-Aldrich
Hydrogen peroxide solution, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O
Boron, monofilament, 200m, diameter 0.1mm
Boron, monofilament, 5m, diameter 0.2mm
Boron, monofilament, 50m, diameter 0.1mm
Boron, monofilament, 10m, diameter 0.2mm
Boron, monofilament, 20m, diameter 0.1mm
Boron, monofilament, 10m, diameter 0.1mm
Boron, monofilament, 5m, diameter 0.1mm
Fructose, European Pharmacopoeia (EP) Reference Standard